Cancer breathlessness breakthrough? common drug put to the test
NCT ID NCT03367156
Summary
This study is testing whether a common steroid drug called dexamethasone can help control severe shortness of breath in cancer patients. About 135 participants with cancer and significant breathlessness were randomly assigned to receive either the drug or a placebo for two weeks. The main goal is to see if the drug reduces the intensity of the symptom and improves quality of life compared to the dummy pill.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DYSPNEA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Harris Health System Settegast Health Center
Houston, Texas, 77028, United States
-
Lyndon B. Johnson Hospital
Houston, Texas, 77026, United States
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.